Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction
出版年份 2021 全文链接
标题
Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction
作者
关键词
-
出版物
Frontiers in Cardiovascular Medicine
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-04-22
DOI
10.3389/fcvm.2021.678530
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence
- (2020) Alberto Aimo et al. PHARMACOLOGICAL RESEARCH
- Heart failure with preserved ejection fraction diagnosis and treatment: An updated review of the evidence
- (2020) Marco Giuseppe Del Buono et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Myeloperoxidase and related biomarkers are suggestive footprints of endothelial microvascular inflammation in HFpEF patients
- (2020) Camilla Hage et al. ESC Heart Failure
- Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial
- (2020) Rolf Wachter et al. ESC Heart Failure
- Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF
- (2020) Jonathan W. Cunningham et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium
- (2020) Donato Cappetta et al. PHARMACOLOGICAL RESEARCH
- Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure with Preserved Ejection Fraction:Results from the PROMIS-HFpEF Study
- (2020) Sandra Sanders-van Wijk et al. CIRCULATION
- Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction
- (2020) Paul W. Armstrong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction
- (2020) James E. Udelson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pirfenidone is Associated with Decreased Indexed End Diastolic and Systolic Volumes in Patients with HFpEF and a Known History of Idiopathic Pulmonary Fibrosis
- (2020) Shehab AlAnsari et al. JOURNAL OF CARDIAC FAILURE
- Association of Coronary Microvascular Dysfunction With Heart Failure Hospitalizations and Mortality in Heart Failure With Preserved Ejection Fraction: A Follow-up in the PROMIS-HFpEF Study
- (2020) Camilla Hage et al. JOURNAL OF CARDIAC FAILURE
- Pirfenidone in Heart Failure with Preserved Ejection Fraction—Rationale and Design of the PIROUETTE Trial
- (2019) Gavin A. Lewis et al. CARDIOVASCULAR DRUGS AND THERAPY
- Heart Failure With Preserved Ejection Fraction In Perspective
- (2019) Marc A. Pfeffer et al. CIRCULATION RESEARCH
- Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction
- (2019) Sanjiv J. Shah et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Responses to Pirfenidone Treatment in Patients with Idiopathic Pulmonary Fibrosis is Not Associated with Changes in Echocardiographic Parameters of Left Ventricular Structure and Function
- (2019) Shehab AlAnsari et al. JOURNAL OF CARDIAC FAILURE
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
- (2019) Domenico D’Amario et al. Frontiers in Physiology
- IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction
- (2018) Benjamin W. Van Tassell et al. Circulation-Heart Failure
- Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF
- (2018) Sanjiv J Shah et al. EUROPEAN HEART JOURNAL
- Treating heart failure with preserved ejection fraction: learning from pulmonary fibrosis
- (2018) Francesca Graziani et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction
- (2018) Barry A. Borlaug et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction
- (2017) Viviany R Taqueti et al. EUROPEAN HEART JOURNAL
- Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study
- (2017) Burkert Pieske et al. EUROPEAN HEART JOURNAL
- Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial
- (2017) Michel Komajda et al. EUROPEAN JOURNAL OF HEART FAILURE
- SIRT3 inhibits Ang II-induced transdifferentiation of cardiac fibroblasts through β-catenin/PPAR-γ signaling
- (2017) Xiaobin Guo et al. LIFE SCIENCES
- Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling
- (2017) Yassine Sassi et al. Nature Communications
- Sirtuin 6 inhibits epithelial to mesenchymal transition during idiopathic pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling
- (2017) Kunming Tian et al. Oncotarget
- The sirtuin 6 prevents angiotensin II-mediated myocardial fibrosis and injury by targeting AMPK-ACE2 signaling
- (2017) Zhen-Zhou Zhang et al. Oncotarget
- Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction
- (2017) Jasper Tromp et al. JACC-Heart Failure
- Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction
- (2017) Erik B. Schelbert et al. JAMA Cardiology
- The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift
- (2016) Filippo Crea et al. EUROPEAN HEART JOURNAL
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy
- (2016) Donato Cappetta et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction
- (2016) Karl-Philipp Rommel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pirfenidone exhibits cardioprotective effects by regulating myocardial fibrosis and vascular permeability in pressure-overloaded hearts
- (2015) Kiyoshi Yamagami et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Pharmacokinetic evaluation of tissue distribution of pirfenidone and its metabolites for idiopathic pulmonary fibrosis therapy
- (2015) Kohei Togami et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction: Contributions of Collagen and Titin
- (2015) M. R. Zile et al. CIRCULATION
- Sirt7 Contributes to Myocardial Tissue Repair by Maintaining Transforming Growth Factor-β Signaling PathwayCLINICAL PERSPECTIVE
- (2015) Satoshi Araki et al. CIRCULATION
- Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial
- (2015) Elke S. Hoendermis et al. EUROPEAN HEART JOURNAL
- Association of impaired left ventricular twisting-untwisting with vascular dysfunction, neurohumoral activation and impaired exercise capacity in hypertensive heart disease
- (2015) Ignatios Ikonomidis et al. EUROPEAN JOURNAL OF HEART FAILURE
- Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction
- (2015) Margaret M. Redfield et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Think Small and Examine the Constituents of Left Ventricular Hypertrophy and Heart Failure: Cardiomyocytes Versus Fibroblasts, Collagen, and Capillaries in the Interstitium: Figure 1.
- (2015) Erik B. Schelbert et al. Journal of the American Heart Association
- Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial
- (2014) Frank Edelmann et al. EUROPEAN JOURNAL OF HEART FAILURE
- The Antifibrotic Effects and Mechanisms of MicroRNA-26a Action in Idiopathic Pulmonary Fibrosis
- (2014) Haihai Liang et al. MOLECULAR THERAPY
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Microvascular-Myocardial Diastolic Dysfunctional State and Risk for Mental Stress Ischemia
- (2014) Carl J. Pepine et al. JACC-Cardiovascular Imaging
- Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)
- (2013) Benjamin Wallace Van Tassell et al. AMERICAN JOURNAL OF CARDIOLOGY
- Pirfenidone Attenuates Cardiac Fibrosis in a Mouse Model of TAC-Induced Left Ventricular Remodeling by Suppressing NLRP3 Inflammasome Formation
- (2013) Yongliang Wang et al. CARDIOLOGY
- Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target
- (2013) N. Glezeva et al. HEART FAILURE REVIEWS
- Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
- (2013) Frank Edelmann et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction
- (2013) Margaret M. Redfield et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
- (2013) Walter J. Paulus et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Biomarkers of Diastolic Dysfunction and Myocardial Fibrosis: Application to Heart Failure with a Preserved Ejection Fraction
- (2013) Michael R. Zile et al. Journal of Cardiovascular Translational Research
- Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF)
- (2012) Kazuhiro Yamamoto et al. EUROPEAN JOURNAL OF HEART FAILURE
- NF-κB mediated miR-26a regulation in cardiac fibrosis
- (2012) Chuanyu Wei et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells
- (2012) Keiko Hisatomi et al. BMC Pulmonary Medicine
- Prognostic Utility of ST2 in Patients with Acute Dyspnea and Preserved Left Ventricular Ejection Fraction
- (2011) K. B. Shah et al. CLINICAL CHEMISTRY
- Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study
- (2011) Viviane M. Conraads et al. EUROPEAN JOURNAL OF HEART FAILURE
- The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice
- (2011) Takanori Yamazaki et al. HYPERTENSION RESEARCH
- Pentraxin 3 Is a New Inflammatory Marker Correlated With Left Ventricular Diastolic Dysfunction and Heart Failure With Normal Ejection Fraction
- (2011) Junichi Matsubara et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pirfenidone
- (2011) Luca Richeldi et al. NATURE REVIEWS DRUG DISCOVERY
- In Vitro Effects of Pirfenidone on Cardiac Fibroblasts: Proliferation, Myofibroblast Differentiation, Migration and Cytokine Secretion
- (2011) Qiang Shi et al. PLoS One
- miR-29 Is a Major Regulator of Genes Associated with Pulmonary Fibrosis
- (2010) Leah Cushing et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- A Randomized Double-Blind Trial of Enalapril in Older Patients With Heart Failure and Preserved Ejection Fraction
- (2010) Dalane W. Kitzman et al. Circulation-Heart Failure
- Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction
- (2010) Dirk Westermann et al. Circulation-Heart Failure
- Pirfenidone mitigates left ventricular fibrosis and dysfunction after myocardial infarction and reduces arrhythmias
- (2010) Duy T. Nguyen et al. HEART RHYTHM
- Central obesity: Association with left ventricular dysfunction and mortality in the community
- (2008) Khawaja Afzal Ammar et al. AMERICAN HEART JOURNAL
- Role of Left Ventricular Stiffness in Heart Failure With Normal Ejection Fraction
- (2008) Dirk Westermann et al. CIRCULATION
- Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction
- (2008) Barry M. Massie et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now